Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis

Journal of the American Academy of Dermatology
Pingxing Xie, Philippe Lefrançois

Abstract

Sonic hedgehog inhibitors (SHHis) provide an additional treatment option for basal cell carcinomas (BCCs), especially for metastatic or locally advanced BCC. However, studies have been heterogeneous and lacked direct comparisons between molecules. To determine the efficacy and safety of the class of molecules SHHi for treating BCC and to compare them individually. We performed a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)-compliant systematic review of studies followed by a meta-analysis. Eighteen articles were included in our meta-analysis; 16 articles were combined for efficacy and 16 for safety. In locally advanced BCC, overall response rates (ORRs) were similar for vismodegib and sonidegib (69% vs 57%, respectively) but not complete response rates (31% vs 3%, respectively). In metastatic disease, the ORR of vismodegib was 2.7-fold higher than the ORR of sonidegib (39% vs 15%, respectively). For side effects affecting a majority of patients, prevalences for muscle spasms (67.1%), dysgeusia (54.1%), and alopecia (57.7%) were in similar proportions for sonidegib and vismodegib. Patients receiving sonidegib experienced more upper gastrointestinal distress than patients receiving vismodegib. SHHis...Continue Reading

Citations

Feb 12, 2019·Current Treatment Options in Oncology·Keiji Tanese
Nov 15, 2019·The American Journal of Surgical Pathology·Ivan J StojanovLynette M Sholl
Mar 25, 2020·International Ophthalmology Clinics·Davin C Ashraf, M Reza Vagefi
Jul 30, 2019·Frontiers in Medicine·Keiji TaneseTakeru Funakoshi
Sep 26, 2020·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·Jerome SrourElke Sattler
Dec 4, 2019·Nature Reviews. Clinical Oncology·Joseph A ClaraNaoko Takebe
May 21, 2020·Diabetes & Metabolism Journal·Kerstin RohdeMatthias Blüher
Nov 28, 2019·Current Treatment Options in Oncology·Erica LeavittStephanie Martin
Apr 17, 2020·Dermatology and Therapy·Alessia VillaniMassimiliano Scalvenzi
Dec 14, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Priyadharsini NagarajanAmanda Ewart Toland
Jul 10, 2019·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ketty PerisUNKNOWN European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Rese
Dec 25, 2019·Journal of the American Academy of Dermatology·Babette J A VerkouterenKlara Mosterd
Mar 18, 2021·Dermatologic Therapy·Elvira MoscarellaRoberto Alfano
Jan 27, 2021·Journal of the American Academy of Dermatology·Frederick C MorganChrysalyne D Schmults
Apr 26, 2020·Journal of the American Academy of Dermatology·Alana DeutschBeth N McLellan
Jul 27, 2021·Bulletin du cancer·Stanislas QuesadaFrédéric Fiteni
Jul 21, 2021·Hematology/oncology Clinics of North America·Gino K InAnn W Silk
Apr 16, 2019·Journal of Medicinal Chemistry·Ilya GalperinMatthias Lauth
Aug 24, 2021·International Journal of Dermatology·Akash D PatelMeenal Kheterpal
Jan 21, 2021·Dermatology : International Journal for Clinical and Investigative Dermatology·Hélène MarescassierMarie Masson Regnault
Jan 28, 2022·Expert Opinion on Pharmacotherapy·Egle RamelyteReinhard Dummer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Basal Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.